β2-microglobulin has a different regulatory molecular mechanism between ER+ and ER− breast cancer with HER2−

β2-microglobulin has a different regulatory molecular mechanism between ER+ and ER− breast cancer with HER2−

Abstract Background Previous studies have demonstrated that β2-microglobulin (β2M) promotes the growth and survival of a variety of cancer cells and has different regulatory effects on the expression of Bcl-2 and HER2 in HER2− breast cancer cells. However, β2M-mediated signaling in ER+ and ER− breas...

Full description

Bibliographic Details
Main Authors: Dandan Chai, Kesheng Li, Huifen Du, Suisheng Yang, Rong Yang, Yang Xu, Xiaowen Lian
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Cancer
Subjects:
β2M
Regulatory
Molecular
Mechanism
Breast cancer
Online Access:http://link.springer.com/article/10.1186/s12885-019-5410-1

Internet

http://link.springer.com/article/10.1186/s12885-019-5410-1

Similar Items